Partnership to Fight Chronic Disease (Pfcd)
A multi-stakeholder organization committed to addressing chronic disease
Based in DC
AI Overview
With $160K in lobbying spend across 8 quarterly filings, Partnership to Fight Chronic Disease (Pfcd) is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2021.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $40K |
| 2021 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Partnership to Fight Chronic Disease (Pfcd) disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Lobbying the Congress on issues related to addressing the threat of Antimicrobial Resistance (AMR) including the DISARM Act as well as efforts to establish a subscription model for the sale and use of
Lobbying the Congress on issues related to the threat of Antimicrobial Resistance (AMR) including the DISARM Act as well as efforts to establish a prescription model for the sale of new antibiotics
Lobbying the Congress on issues related to the threat of Antimicrobial Resistance (AMR) including the DISARM Act and Pasteur Act as well as efforts to establish a prescription model for the sale of ne
The need for Congress to pass new financial incentives to support the development of new antibiotics as well as other steps to combat Antimicrobial Resistance.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.